Pruefengel Institute Expands Global Presence and Enters the US Market

In a landmark move, the Pruefengel Institute is expanding its global footprint by entering the American market. This strategic expansion is a significant milestone for Pruefengel, signaling its commitment to bringing its renowned testing services to a wider audience. By making its test reports available in multiple languages, including English, Spanish, Italian, French, Polish, and Dutch, Pruefengel is not just crossing geographical boundaries but also breaking down language barriers, making its comprehensive evaluations accessible to consumers across the globe.

Strategic Market Entry

The decision to enter the American market is a calculated step towards enhancing Pruefengel’s global presence. Recognizing the vast potential and the dynamic nature of the American consumer base, Pruefengel aims to establish itself as a key player in the product and service testing industry within the United States. This move is part of a broader vision to cater to the needs of global consumers by providing transparent, detailed, and reliable test reports in their native languages.

Multilingual Accessibility

With the launch of test reports in multiple languages on June 23, 2023, Pruefengel has significantly widened its reach. This initiative ensures that consumers from diverse linguistic backgrounds can access vital information about products and services, facilitating informed purchasing decisions. The availability of the Pruefengel quality seal in these languages further reinforces the trust and confidence international customers place in the Pruefengel brand.

Enhancing Consumer Confidence in the US

By making its resources available in multiple languages, Pruefengel addresses a crucial market need in the US—access to reliable and comprehensible product evaluations. American consumers, alongside international customers residing in the US, can now benefit from Pruefengel’s expert assessments in their preferred language, boosting consumer confidence and aiding in smarter purchasing decisions.

Online Accessibility and Broadened Reach

Pruefengel’s official website now hosts the multilingual test reports, making it easier for customers, especially those in the US, to learn about the institute’s services. This online accessibility is expected to not only broaden Pruefengel’s reach but also strengthen its market presence internationally and particularly in the US.

Conclusion

The Pruefengel Institute’s entry into the American market represents a significant step forward in its global strategy. By offering test reports in multiple languages and catering to the needs of a diverse clientele, Pruefengel is set to become a pivotal resource for consumers looking for unbiased, thorough evaluations of products and services. This expansion not only showcases Pruefengel’s commitment to accessibility and consumer empowerment but also positions it as a trusted authority in product and service testing on a global scale.

Media Contact
Company Name: Prüfengel Institut GmbH
Contact Person: Micha Rienecker
Email: Send Email
Phone: 0931 / 8008021-0
Country: Germany
Website: https://pruefengel.org/

Pruefengel Instills Confidence in the US Consumer Market

Pruefengel’s latest venture into the US market signifies a monumental step towards enhancing consumer trust and confidence in product quality and safety. By extending its independent product certification services to American companies, Pruefengel is not just expanding its geographical footprint but is also reinforcing its commitment to upholding high standards of product reliability and transparency. This initiative aims to empower US consumers with the assurance that the products they choose meet stringent testing criteria, fostering a safer and more trustworthy shopping environment.

Cultivating Trust with Independent Certification

Pruefengel’s entry into the US market is driven by the objective to introduce a new level of trust and reliability in products available to American consumers. By offering its certification services, Pruefengel provides an independent verification that products comply with the highest standards of quality and safety. This move is particularly timely, addressing the increasing consumer demand for verified and safe products amidst a crowded and often confusing market landscape.

Accessibility of Services Across Languages

Recognizing the diverse linguistic landscape of the US, Pruefengel has made its certification reports available in multiple languages as of June 23, 2023. This inclusive approach ensures that all US consumers, regardless of their primary language, can access detailed and transparent information about the certified products. English, Spanish, Italian, French, Polish, and Dutch are among the languages offered, making Pruefengel’s services more accessible and comprehensible to a broad audience.

Enhancing Consumer Confidence

The availability of Pruefengel’s independent product certifications in the US market is a significant advantage for both consumers and companies. For consumers, it means access to a higher level of product assurance, which in turn can lead to more informed purchasing decisions. For companies, the Pruefengel certification seal represents a powerful tool to distinguish their products by demonstrating a commitment to excellence and safety, thereby building consumer trust and loyalty.

Facilitating Easy Access Through Digital Platforms

Pruefengel has streamlined access to its certification services and reports through its official website, allowing US consumers and businesses to easily obtain the information they need. This digital accessibility is crucial for expanding Pruefengel’s reach within the US, ensuring that its services have a positive impact on the consumer market by promoting transparency and trust in certified products.

Conclusion

Pruefengel’s strategy to bring its esteemed product certification services to the US market is a clear indication of its dedication to fostering a safer and more reliable consumer environment. By instilling confidence through independent verification, Pruefengel is setting a new standard in consumer trust, making a significant contribution to the integrity of the US consumer market. This initiative not only benefits American consumers but also supports companies in achieving a competitive edge through the assurance of quality and safety.

Media Contact
Company Name: Prüfengel Institut GmbH
Contact Person: Micha Rienecker
Email: Send Email
Phone: 0931 / 8008021-0
Country: Germany
Website: https://pruefengel.org/

Independent Product Certification Now Available for US Companies

The Pruefengel Institute is broadening its horizons with a significant foray into the American market, marking a pivotal development in its mission to offer independent product certification on a global scale. This expansion reflects Pruefengel’s dedication to delivering its esteemed testing and certification services to a broader audience, with a special emphasis on catering to the needs of US-based companies. By providing test reports in various languages, Pruefengel ensures that its comprehensive evaluations are accessible to a wide range of consumers worldwide, promoting transparency and reliability in product quality.

Expanding Services to the US Market

Entering the US market, Pruefengel aims to fill a crucial gap by offering independent, unbiased evaluations and certifications for products across various sectors. This move is strategic, targeting the dynamic and diverse American business landscape where there is a growing demand for certified products that meet high standards of quality and safety. Pruefengel’s initiative to make its services available in the US is a testament to its commitment to excellence and consumer trust.

Multilingual Report Accessibility

With the initiation of services in the US on June 23, 2023, Pruefengel has made its test reports available in several languages, including English, Spanish, Italian, French, Polish, and Dutch. This multilingual approach ensures that US companies and consumers alike can access crucial information in their preferred language, facilitating better understanding and decision-making regarding product certifications.

Building Trust with US Consumers

For US companies, the availability of Pruefengel’s independent certification services means an opportunity to distinguish their products in a competitive market. By leveraging Pruefengel’s reputable certification seal, companies can enhance consumer confidence, demonstrating a commitment to quality and safety that resonates with the values of American consumers.

Streamlined Online Access

Pruefengel has made it easier for US businesses and consumers to access its test reports and certification services through its official website. This online platform serves as a resourceful hub where users can find detailed evaluations and certification information in multiple languages, thus expanding Pruefengel’s reach and solidifying its presence in the international and US markets.

Conclusion

The introduction of Pruefengel’s independent product certification services in the United States is a game-changer for US companies seeking to certify the quality and safety of their products. This expansion is aligned with Pruefengel’s goal of globalizing its services, offering US businesses and consumers access to reliable, unbiased product evaluations. As Pruefengel establishes itself in the American market, its commitment to transparency, quality, and consumer trust is set to redefine standards in product certification and testing.

Media Contact
Company Name: Prüfengel Institut GmbH
Contact Person: Micha Rienecker
Email: Send Email
Phone: 0931 / 8008021-0
Country: Germany
Website: https://pruefengel.org/

Break Free From Childhood Limitations With Kathi Sohn’s Latest Book: “You Made It Up, Now Stop Believing It”

Break Free From Childhood Limitations With Kathi Sohn’s Latest Book: "You Made It Up, Now Stop Believing It"

Are you ready to unleash your true potential and live the life you’ve always dreamed of? Renowned author and transformational coach Kathi Sohn reveals the path to personal liberation in her latest book, “You Made it Up, Now Stop Believing It: The Powerful Body Memory Process for Childhood Vow Discovery and Release.” With this compelling guide, readers can finally break free from the shackles of childhood beliefs and embark on a journey of self-discovery, growth, and empowerment.

As young children, we create stories about ourselves, others, and life to navigate the world around us. These stories, known as childhood vows, shape our beliefs and influence every aspect of our adult lives, often holding us back from reaching our full potential. In “You Made it Up, Now Stop Believing It,” Kathi Sohn delves into the science of body memory and its role in preserving these vows within us.

The heart of this groundbreaking book lies in its unique approach to self-liberation. Through insightful narratives and real-life testimonials, readers gain valuable insights into how vows manifest in their adult lives and how they can be released. With practical techniques and step-by-step exercises, Kathi Sohn empowers readers to identify and let go of these limiting beliefs, clearing the path for positive transformations.

“You Made it Up, Now Stop Believing It” is a beacon of hope, presenting readers with inspiring stories of individuals who have embraced the vow discovery process. These true-life accounts showcase the power of releasing childhood vows, leading to improved health, enriched relationships, financial abundance, and discovering one’s authentic voice.

Kathi Sohn’s book transcends the self-help genre, offering a powerful and transformative tool for individuals seeking genuine change. By diving into the depths of their subconscious, readers can overcome long-standing obstacles, unleash their true potential, and ultimately lead a life of purpose and fulfillment.

Kathi Sohn is a renowned author, speaker, and transformational coach passionate about helping others break free from limiting beliefs. Her extensive expertise in body memory and healing modalities have empowered countless individuals to overcome their past and embrace a brighter future.

Grab Your Copy Today! You Made it Up, Now Stop Believing It is available for purchase.

About the Author:

Kathi Sohn retired in 2020 from a thirty-six-year federal career to continue her late husband’s groundbreaking work, the Body Memory Process, to heal childhood trauma by revealing and releasing associated self-limiting and self-destructive beliefs. Ms. Sohn learned the work deeply after using the process to heal herself from a paralyzing fear of speaking in a group.

Book Name: You Made it Up, Now Stop Believing It
Author Name: Kathi Sohn
Website: https://youmadeitupbook.com/
ISBN Number: 979-8218186609
Ebook Version: Click Here
Paperback Version: Click Here

Media Contact
Company Name: Amazon Publishing Pros
Email: Send Email
Phone: +1-877-992-7638
Country: United States
Website: https://www.amazonpublishingpros.co

Trial Endpoint Reached for First Suicidal Bipolar Depression, Chronic Pain and PTSD Drug; Agreement with Partners Can Provide up to $329 Million and Royalties: NRx Pharmaceuticals (Nasdaq: NRXP)

– Developing Therapeutics for the Treatment of CNS Disorders, Specifically Suicidal Bipolar Depression, Chronic Pain, and PTSD.

– Reached Last Patient, Last Visit in Phase 2b/3 Trial of NRX-101 for Suicidal Treatment-Resistant Bipolar Depression.  

– Study Maintained 95% Concordance Rate Between Study Sites and Central Raters on Primary Endpoint. No Unexpected Serious Adverse Events Reported.

– Positive Sata and FDA Comment Triggers next $4 Million Payment from Partners Alvogen and Lotus and their Assumption of Development Costs with up to $329 Million in Milestone Payments and a Royalty on Net Sales in the Mid-Teens. 

– Launch of HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024, Plus Planned Share Dividend to Existing NRXP Shareholders. 

– Completed Initial Manufacture of IV Infusion and Plans to File FDA New Drug Application for Acute Suicidality Upon Demonstration of 2-ear Shelf Stability.

– Already Received $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

– NRXP Eligible for Additional $320 Million in Development & Sales Milestones, Plus Double-Digit Royalties Upon Approval and Commercialization of NRX-101.

– Completing Enrollment for Phase 2b/3 Trial in Suicidal Treatment-Resistant Bipolar Depression in Cooperation with Lotus Pharmaceutical. 

– Incorporation of HOPE Therapeutics Dedicated to NRX-100 (IV Ketamine) for Suicidal Depression to Patients. 

– HOPE Therapeutics to be Initially Owned by NXRP and current NXRP Shareholders via a Planned Tax-Free Dividend. 

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRXP has partnered with Alvogen Pharmaceuticals around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has the potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRXP has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine) in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRXP was awarded Fast Track Designation for the development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

NRXP Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment-Resistant Bipolar Depression 

On March 4th NRXP announced that the 74th and last evaluable patient has completed their day 42 visit in its Phase 2b/3 study of NRX-101, the Company’s patented combination of the NMDA antagonist D-cycloserine and lurasidone, in Suicidal Treatment Resistant Bipolar Depression.  The NRXP database is being cleaned, finalized, and locked; statistical analysis will then be performed, with top-line data to follow shortly thereafter.  As previously disclosed, positive data from this trial triggers a milestone payment from Alvogen to NRXP. Alvogen will then be responsible for further development and commercialization costs for this program. 

The NRXP NRX-101 treatment has been awarded a Breakthrough Therapy Designation, Fast Track Designation, a Biomarker Letter of Support, and a Special Protocol Agreement by the FDA for the treatment of suicidal bipolar depression. It is the only oral medication to have demonstrated reduced suicidal ideation in patients with bipolar depression, a lethal disease that claims the lives of one in five who live with it.  

The Phase 2b/3 NRXP trial (www.clinicaltrials.gov NCT 03395392) is a randomized, prospective, multicenter, double-blind study comparing NRX-101 to lurasidone over six weeks. The Principal Investigator is Prof. Andrew Nierenberg of Harvard Massachusetts General Hospital. The primary efficacy endpoint is reduction in depression as measured on the MADRS scale and the secondary endpoint is reduction of suicidal ideation as measured by the Clinical Global Impression Suicidality Scale (CGI-SS).  As previously disclosed, treatment compliance and concordance of local raters to central raters’ scores were in excess of 94%, well above the industry standard that is normally seen in CNS trials.

NRXP to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024, Plus Planned Share Dividend to Existing NRXP Shareholders

On February 20th NRXP announced that Dr. Jonathan Javitt, its Chairman and Chief Scient, would present a corporate overview at the BIO CEO & Investor Conference, held February 26-27, 2024 in New York City. Presenting with him would be Matthew Duffy, the newly appointed co-CEO of HOPE Therapeutics.

Concurrent with the presentation, NRXP plans to file a proxy statement, subject to board approval, for NRXP shareholders outlining the share structure and seeking a shareholder advisory vote to support the planned share dividend for HOPE Therapeutics. NRXP has received consistent advice from public shareholders that the planned share dividend and royalty coupon be distributed only to shareholders and warrant-holders who execute a covenant not to participate in short sales of the Company’s stock.

$5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

On February 12th NRXP announced the advance of the first $5 million milestone payment based on the Company’s partnership agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW).

NRXP will immediately receive $5 million of the first milestone, which the Company will use to fund the development of NRX-101 through the phase 2 meeting with FDA. As compensation for advancing the milestone, Alvogen and Lotus will receive 4.1 million warrants to purchase NRXP common stock, at a strike price of $0.40 with a three (3) year term.  The second portion of the milestone will be $4 million and, as before, be triggered by a positive response to the Company’s planned end-of-phase 2 meeting with FDA. 

NRXP then remains eligible to receive up to $320 million in future development and sales milestones, as well as royalty payments escalating to mid-teen percentages on Net Sales, subject to achievement of certain sales volumes.  Additionally, Alvogen and Lotus will be responsible for future development and commercialization costs for the NRXP NRX-101 in the treatment of bipolar depression with suicidality.

Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report

On February 9th NRXP announced that its Asia Pacific strategic partner Lotus Pharmaceutical Co. Ltd (1975.TW) identified enrollment completion of the NRXP clinical trial in bipolar depression as a material event in is February 7 financial filing. Lotus provides the Asia Pacific component of the NRXP global partnership with Alvogen, Inc.

Lotus reported in the accompanying press release that “Lotus Pharmaceutical’s strategic partner, NRXP, has achieved a significant milestone by completing enrollment for its phase 2b/3 trial of NRX-101 in suicidal treatment-resistant bipolar depression. The readout for this trial is anticipated in Q2 of this year.”

Incorporation of HOPE Therapeutics & Planned Share Dividend/Royalty Coupon

On February 5th NRXP announced the incorporation of HOPE Therapeutics™, a biotechnology company dedicated to bringing NRX-100 (IV Ketamine), which will be re-designated HTX-100, a potentially lifesaving treatment option for patients with Suicidal Depression. The company will initially be owned by NRXP and its current shareholders, who will receive their shares in the form of a dividend with an accompanying royalty coupon tied to future sales of HTX-100, subject to Board approval. This is designed with counsel to not be a taxable event for NRXP shareholders.

HOPE is dedicated to providing an FDA-approved presentation of IV Ketamine, manufactured to current federal standards, in a diversion- and abuse-deterrent presentation. A New Drug Application (NDA) is planned for the first half of 2024, based on more than 1,000 patients treated in well-controlled trials of ketamine in Suicidal Depression together with HOPE’s expertise in sterile product formulation.

Importantly, NRXP intends to provide state-of-the-art patient and reimbursement support for all of its patients and their clinics. Access to insurance coverage is critical for providing treatment to this vulnerable population and can only be achieved through the development of an FDA-approved product. Additionally, providing an approved, compliant product for patients allows clinics to deliver state-of-the-art care to people suffering from suicidality without fear of legal and regulatory actions. 

For more information on $NRXP visit: https://www.nrxpharma.com/

And https://axecapitalusa.com/nrxp/

DISCLAIMER:

CAP/FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CAP/FPS/CA is NOT affiliated in any manner with any company mentioned herein. CAP/FPS/CA is a news dissemination solutions provider and is NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. CAP/FPS/CA’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or the opinion of the writer. CAP/FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CAP/FPS/CA has been compensated $500 by a third party for the dissemination of this article.

Disclaimer/Safe Harbor:

These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.

Media Contact
Company Name: NRx Pharmaceuticals, Inc.
Contact Person: Jonathan Javitt, Founder of $NRXP
Email: Send Email
Phone: 484 254 6134
Address:1201 Orange Street Suite 600
City: Wilmington
State: Delaware 19801
Country: United States
Website: https://www.nrxpharma.com/

Microgrid Market Powers Up, Envisioned to Reach USD 87.8 Billion by 2029, at a CAGR of 18.5%

“Microgrid Market”
The global Microgrid Market Value is projected to be USD 87.8 billion by 2029, growing from USD 37.6 billion in 2024, at a Compound Annual Growth Rate (CAGR) of 18.5% during the forecast period.

The Global Microgrid Market is poised for substantial growth, with a projected market size of USD 87.8 billion by 2029. This anticipated surge reflects a robust Compound Annual Growth Rate (CAGR) of 18.5% from 2024 to 2029, according to a comprehensive report by MarketsandMarkets, a leading provider of market research and consulting services.

Microgrids, decentralized energy systems that operate independently or in conjunction with the main power grid, have emerged as a dynamic solution to address the evolving energy landscape. The projected growth of the Microgrid Market is fueled by factors such as the increasing demand for reliable and resilient energy sources, advancements in renewable energy technologies, and the growing focus on sustainable and off-grid power solutions.

Download PDF Brochure @ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=917

Microgrid Market

Key Segments:

Type Segment: The Microgrid Market is segmented based on type, including grid-connected and off-grid microgrids. Grid-connected microgrids integrate with the main power grid, while off-grid microgrids operate independently, often in remote or rural areas.

Component Segment: Components of microgrids include distributed energy resources (DERs), energy storage systems, power inverters, and controls. Each component plays a crucial role in the efficient operation of microgrid systems.

Vertical Segment: Microgrids cater to various industry verticals, including healthcare, education, military, and commercial and industrial sectors. The application of microgrids varies across these verticals to meet specific energy needs.

Inquire Before Buying @
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=917

Growth Drivers:

Demand for Reliable and Resilient Energy Sources: The increasing need for reliable and resilient energy sources, especially in the face of natural disasters and grid disruptions, propels the adoption of microgrid solutions.

Advancements in Renewable Energy Technologies: Continuous advancements in renewable energy technologies, such as solar and wind power, contribute to the viability and efficiency of microgrid systems.

Focus on Sustainable and Off-Grid Power Solutions: Growing environmental concerns and the emphasis on sustainable and off-grid power solutions drive the deployment of microgrids as a viable and eco-friendly energy alternative.

Challenges:

Initial High Capital Costs: The implementation of microgrid systems often involves high upfront capital costs, which may pose a challenge for certain markets and potential investors.

Complex Regulatory Landscape: The complex regulatory landscape and varying policies related to microgrid deployment across different regions can present obstacles to widespread adoption.

View detailed Table of Content here –
https://www.marketsandmarkets.com/Market-Reports/micro-grid-electronics-market-917.html  

Opportunities:

Increasing Investment in Renewable Energy Infrastructure: Rising investments in renewable energy infrastructure projects worldwide create opportunities for the integration of microgrids into the evolving energy landscape.

Growing Focus on Energy Independence: The growing focus on achieving energy independence, especially in remote and underserved regions, opens avenues for the deployment of off-grid microgrids.

Key Players:

The report identifies key players in the global Microgrid Market, including:

Schneider Electric SE: A global leader in energy management and automation, Schneider Electric provides solutions for microgrid controls, energy storage, and power distribution.

Siemens AG: Siemens is a prominent player in the microgrid market, offering a range of solutions for distributed energy systems, energy management, and grid control.

ABB Group: ABB Group specializes in power and automation technologies, providing solutions for microgrid integration, control systems, and energy storage.

General Electric Company: General Electric is a leading provider of power and energy solutions, offering microgrid technologies for enhanced energy efficiency and reliability.

Honeywell International Inc.: Honeywell provides advanced microgrid solutions, including controls, energy storage, and distributed energy resources, to optimize energy usage.

The global Microgrid Market is witnessing significant growth, driven by the demand for reliable and resilient energy sources, advancements in renewable energy technologies, and the focus on sustainable and off-grid power solutions. As the world continues to transition towards a more sustainable energy future, microgrids play a pivotal role in shaping the decentralized and resilient power systems of tomorrow.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/micro-grid-electronics-market-917.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Microgrid Market Powers Up, Envisioned to Reach USD 87.8 Billion by 2029, at a CAGR of 18.5%

Affordable and High-Quality Rhinoplasty Experience in Turkey with Lygos Clinic

Turkey has gained a worldwide reputation in the field of cosmetic surgery, particularly excelling in rhinoplasty. Among the leading clinics in this area, Lygos Clinic stands out for its high-quality and affordable services under the leadership of its founder, Sinan Ozer. Ozer explains why Turkey is one of the most popular countries for nose jobs and reveals the secrets behind Lygos Clinic’s success in this field.

Sinan Ozer states, “In recent years, Turkey has shown significant progress in rhinoplasty. With our professional surgeons and the latest techniques, we offer services that meet global standards.” He attributes Turkey’s popularity in this field to the presence of trained professional surgeons, the successful application of the latest techniques, and cost-effectiveness.

Ozer also touches on the subject of rhinoplasty cost: “While the cost of getting a rhinoplasty in Turkey varies between $3,000 to $5,500, in European countries, this cost can range from $5,500 to $15,000. Although the cost varies depending on the individual’s demands and needs, our clinic’s competitive prices make us a choice for international patients as well.”

The founder of Lygos Clinic adds, “Nose jobs and surgery are not just an aesthetic choice but also directly affect a person’s breathing, sleep quality, and thus their quality of life. That’s why we offer personalized approaches to each of our patients, providing solutions that meet their needs and expectations.”

Another reason for the popularity of rhinoplasty in Turkey, according to the founder of Lygos Clinic, is the opportunity for patients to vacation during their surgery. “Our patients not only receive world-class healthcare services but also have the chance to explore the unique beauty of Turkey. This makes their recovery process more enjoyable, which is our greatest joy.”

In conclusion, Sinan Ozer and Lygos Clinic reinforce Turkey’s leadership in rhinoplasty with expert surgeons, cutting-edge technology applications, and affordable costs. This comprehensive approach is one of the main reasons both local and international patients choose Turkey for their nose jobs. Lygos Clinic continues to prioritize patient satisfaction, offering personalized treatment plans and aiming for excellence in cosmetic surgery.

Media Contact
Company Name: Lygos Clinic
Contact Person: Sinan Ozer
Email: Send Email
Phone: +90530 125 31 91
Country: Turkey
Website: https://lygosclinic.com/tr/burun-estetigi/

Scottsdale Strippers Awarded Most Popular Pool Party Entertainers in Arizona

Scottsdale, AZ – March 04, 2024 – In a dazzling celebration of talent and entertainment, Scottsdale Strippers have been officially recognized as the Most Popular Pool Party Entertainers in Arizona. This prestigious accolade is a testament to the exceptional performance, professionalism, and vibrant energy that the Scottsdale entertainers bring to every poolside event.

Known for their captivating performances, Scottsdale Strippers have become synonymous with creating unforgettable experiences at pool parties across Arizona. Their ability to blend skillful choreography with interactive engagement has set them apart in the competitive entertainment scene.

What makes Scottsdale Strippers the go-to choice for pool parties in Arizona is not just their striking appearance, but also their dedication to delivering top-notch entertainment. The entertainers are carefully selected for their charisma, talent, and commitment to ensuring every event is an extraordinary affair.

From private celebrations to larger-than-life pool parties, Scottsdale Strippers have mastered the art of tailoring their performances to suit the unique atmosphere of each gathering. Their diverse range of talents, including mesmerizing dance routines and crowd-pleasing interactive acts, guarantees an immersive experience for partygoers.

Scottsdale Strippers takes pride in the positive feedback received from clients and event attendees. The recognition as the Most Popular Pool Party Entertainers in Arizona is not only an acknowledgment of their outstanding performances but also a reflection of the joy and excitement they bring to the Arizona entertainment scene.

For those looking to elevate their poolside events with unparalleled entertainment, Scottsdale Strippers remains the ultimate choice. With a commitment to excellence and a reputation for delivering sensational shows, they continue to set the standard for pool party entertainment in Arizona. https://scottsdaleentertainers.com/scottsdale-pool-party-strippers/

Scottsdale Strippers is a leading entertainment agency based in Arizona, specializing in providing top-tier performers for various events, including pool parties, bachelor parties, and private celebrations. With a focus on delivering exceptional experiences, Scottsdale Strippers has earned a reputation as the go-to source for high-quality adult entertainment in the state.

Media Contact
Company Name: Scottsdale Entertainers
Contact Person: Jessica Sue
Email: Send Email
Phone: 602-661-1414
City: Scottsdale
State: Arizona
Country: United States
Website: www.scottsdaleentertainers.com/

Slice Partners with Bitrefill to Empower Users with More Choices to Spend Their SATs.

Revolutionizing Digital Earnings: Slice and Bitrefill Team Up to Democratize Online Earnings and Spending in Crypto.

Slice

California – In 2023, humanity spent over 1.3 billion years browsing the internet, with more than 80% of the economic value created from this activity funneled into the pockets of a few tech giants. The time has come to democratize the internet, making it fair and profitable for everyone.

Slice

Introducing Slice, the world’s first advertising solution built on modern internet browsing. The website is committed to personal monetization and data privacy, ensuring that users get their fair slice of the massive revenue pie generated online.

Today, Slice is thrilled to announce its partnership with Bitrefill, a leading platform that turns crypto into gift cards. Bitrefill’s innovative approach aligns perfectly with Slice’s mission to provide users with more choices and control over their earnings.

Slice

Bitrefill has been making waves in the crypto community, allowing users to live on crypto by converting their digital assets into gift cards for major retail and online outlets. This partnership with Slice opens up new opportunities for users to spend their seats on everything from morning coffee to online courses or even dream vacations.

Bitrefill’s “gaming” section is a treasure trove for gamers, offering instant access to top gaming products like Steam, PlayStation Store, Nintendo eShop, and more. From Minecraft to Fortnite, Roblox to Super Mario, Bitrefill provides a seamless way to buy video games with Bitcoin, allowing gamers to live bankless and save on exchange fees. They believe that Bitrefill’s gaming offerings will particularly appeal to the majority of Slice users, enhancing their gaming experience and providing more choices to spend their seats.

Darina Oumanski, CEO and Co-Founder of Slice, said, “This partnership with Bitrefill is a powerful statement. We’re not just offering another way to spend your earnings; we’re embracing the unconditional freedom of choice when it comes to users’ accumulated sats. Bitrefill’s innovative approach resonates with our vision at Slice, and together, we’re empowering users to take control in choosing how they want to live, play, and thrive online and offline.”

Sergej Kotliar, CEO of Bitrefill, said, “Slice’s innovative approach to advertising and user engagement resonates with our mission at Bitrefill. This partnership is an exciting opportunity to expand our reach into the gaming community and offer a unique way to leverage time online into real rewards. We’re proud to join forces with Slice, a company that shares our belief in the power of the circular crypto economy.”

Slice

Slice continues to push the boundaries of innovation, providing users with effortless streams of income and playful rewards for nearly 275K users after the launch in 2022. Their partnership with Bitrefill is just the beginning. They are committed to building a community where browsing and playing games earn their real rewards.

The advertisement market is projected to hit $1 trillion by 2027, and they’re leveraging these extraordinary projections to balance the future where profit-sharing is not an exception but a norm. Where the streamer economy thrives, and where user engagement is not just encouraged but celebrated. With Bitrefill, they’re adding another layer of choice, enabling instant payouts without withdrawal fees.

Users can join them in this exciting journey as they redefine the way users interact with the internet. With Slice and Bitrefill, users are not just passive consumers; they’re active participants in a new era of digital empowerment.

For more information about Slice and their partnership with Bitrefill, visit https://addslice.com/ and https://www.bitrefill.com/

About Slice: 

Slice is the world’s first advertising solution built on modern internet browsing, revolutionizing the way users monetize their online activities while prioritizing data privacy. With a commitment to empowering users, Slice has partnered with Bitrefill, a leading platform that enables users to convert their crypto assets into gift cards. Together, they offer users more choices and control over their earnings, allowing them to spend their digital assets on a wide range of products and services, including gaming, retail, and more. 

Media Contact
Company Name: Slice
Contact Person: Darina Oumanski
Email: Send Email
Country: United States
Website: https://addslice.com

My Country Mobile Launches FloatChat, an AI-powered chatbot

My Country Mobile General Trading LLC launches FloatChat, an AI-powered chatbot for seamless omnichannel communication for businesses.

California – FloatChat plays a crucial role in enabling businesses to achieve seamless omnichannel communication. Without FloatChat, businesses and individuals face significant challenges in achieving seamless omnichannel communication. They may struggle with time-consuming and inefficient manual handling of customer queries across various messaging platforms. Inconsistent responses and delays in addressing customer needs can lead to frustration and dissatisfaction. Additionally, businesses may find it difficult to keep up with the volume of inquiries and provide personalized interactions without the AI-powered capabilities of FloatChat. Overall, the absence of FloatChat can hinder effective customer engagement, hinder business growth, and potentially result in missed opportunities for building strong customer relationships.

However, My Country Mobile, a leading provider of communication solutions for businesses, is excited to announce the launch of FloatChat, a new AI-powered chatbot that offers businesses an omnichannel communication solution. With FloatChat, businesses can engage with their customers on a range of popular messaging platforms, including WhatsApp, Facebook, Skype, Viber, Telegram, Instagram, Messenger, Twitter, Zendex, kik, and websites.

FloatChat’s AI technology allows it to provide personalized responses to customers based on their unique needs and preferences. The chatbot is designed to handle a wide range of customer queries and issues and learns from customer interactions, improving its responses and functionality over time.

My Country Mobile

“Our goal with FloatChat is to provide businesses with an intelligent chatbot that can handle customer queries and issues effectively while improving overall customer satisfaction,” said Furkan Mistry, CTO of My Country Mobile. “With FloatChat’s omnichannel capabilities, businesses can improve their customer communication and build stronger relationships with their customers.”

FloatChat can be accessed through WhatsApp, Facebook, Skype, Viber, Telegram, Instagram, Messenger, Twitter, and the company’s website, ensuring that customers can engage with My Country Mobile via their preferred messaging platform. FloatChat’s AI technology ensures that customers receive timely and accurate responses, reducing response times and improving overall efficiency.

My Country Mobile

My Country Mobile is committed to delivering customer-centric solutions that empower businesses to succeed in an increasingly digital world. The company offers a range of services, including voice, messaging, and video, as well as innovative solutions like FloatChat.

For more information about FloatChat and the website, visit www.mycountrymobile.com

About my Country Mobile: 

My Country Mobile is a leading provider of communication solutions for businesses. With a focus on delivering innovative and customer-centric services, My Country Mobile empowers businesses to communicate seamlessly and efficiently with their customers. The company offers a range of services, including voice, messaging, and video, as well as cutting-edge solutions like FloatChat, an AI-powered chatbot enabling omnichannel communication. With a commitment to excellence and customer satisfaction, My Country Mobile is dedicated to helping businesses succeed in today’s digital landscape.

Media Contact
Company Name: My Country Mobile
Contact Person: SR Khan
Email: Send Email
Phone: +971 56 448 4264, +65 3158 1894, +1(917)-444-7882
Country: United Arab Emirates
Website: http://www.mycountrymobile.com/